Initial commercial orders for the Apyx One console in South Korea are expected in Q4 2025 CLEARWATER FL, December 3, 2025 —Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx [...]
CLEARWATER FL, November 18, 2025 —Apyx® Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body [...]
CLEARWATER FL, November 17, 2025 —Apyx® Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body [...]
Initiated full U.S. commercial launch of AYON Body Contouring System™ (AYON) at end of Q3 2025, with demand for pre-orders exceeding expectations Submitted new 510(k) for AYON for device label [...]
CLEARWATER, FL — October 28, 2025 – Apyx® Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology [...]
CLEARWATER, Fla. — October 28, 2025 – Apyx® Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology [...]
Initiated Nationwide Commercial Launch of AYON in September The Company is Hosting a Virtual Key Opinion Leader Event to Discuss the Commercial Launch of AYON on October 14, 2025 CLEARWATER, FL [...]
This site tracks visits anonymously. Visit our Privacy Policy page to learn more about the data we collect, and the cookies used on this site. If you agree with these policies, click the AGREE button to close this message.
